JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$883M |
| 2 |
Walt Disney
DIS
|
+$735M |
| 3 |
Nike
NKE
|
+$722M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$648M |
| 5 |
Philip Morris
PM
|
+$632M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.21B |
| 2 |
Meta Platforms (Facebook)
META
|
+$689M |
| 3 |
Broadcom
AVGO
|
+$633M |
| 4 |
Gilead Sciences
GILD
|
+$608M |
| 5 |
MetLife
MET
|
+$587M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.21% |
| 2 | Technology | 10.97% |
| 3 | Healthcare | 8.87% |
| 4 | Consumer Discretionary | 8.27% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RARX
2601
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $3.18M | ﹤0.01% |
149,468
-17,348
| -10% | -$332K |
|
2602
Puma Biotechnology
PBYI
$450M
| $3.17M | ﹤0.01% |
85,338
-4,231
| -5% | -$154K |
|
2603
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.75B
| $3.17M | ﹤0.01% |
65,892
+21,264
| +48% | +$1.01M |
|
2604
Peoples Bancorp
PEBO
$1.49B
| $3.17M | ﹤0.01% |
99,953
+72,141
| +259% | +$2.31M |
|
2605
Forward Air
FWRD
$682M
| $3.15M | ﹤0.01% |
66,246
-32,030
| -33% | -$1.55M |
|
2606
STAG Industrial
STAG
$7.12B
| $3.15M | ﹤0.01% |
125,773
-52,836
| -30% | -$1.29M |
|
2607
AutoNation
AN
$6.89B
| $3.14M | ﹤0.01% |
74,318
+17,157
| +30% | +$820K |
|
2608
Integer Holdings
ITGR
$4.25B
| $3.14M | ﹤0.01% |
78,138
+31,349
| +67% | +$1.1M |
|
2609
Employers Holdings
EIG
$871M
| $3.14M | ﹤0.01% |
82,718
-13,275
| -14% | -$501K |
|
|
SIGM
2610
DELISTED
Sigma Designs Inc
SIGM
| $3.13M | ﹤0.01% |
501,617
-4,883
| -1% | -$30.1K |
|
2611
CareTrust REIT
CTRE
$9.18B
| $3.13M | ﹤0.01% |
185,835
-52,048
| -22% | -$808K |
|
|
DTV
2612
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
| $3.12M | ﹤0.01% |
58,135
+2,332
| +4% | +$123K |
|
2613
Triumph Financial Inc
TFIN
$1.87B
| $3.12M | ﹤0.01% |
120,950
-19,203
| -14% | -$509K |
|
2614
New York Times
NYT
$10.3B
| $3.12M | ﹤0.01% |
216,609
-30,350
| -12% | -$434K |
|
|
VIVO
2615
DELISTED
Meridian Bioscience Inc
VIVO
| $3.12M | ﹤0.01% |
226,047
+10,939
| +5% | +$153K |
|
|
ITG
2616
DELISTED
Investment Technology Group Inc
ITG
| $3.11M | ﹤0.01% |
153,675
+68,541
| +81% | +$1.39M |
|
2617
Navios Maritime Partners
NMM
$2.31B
| $3.11M | ﹤0.01% |
100,071
+64,690
| +183% | +$1.79M |
|
|
INXN
2618
DELISTED
Interxion Holding N.V.
INXN
| $3.1M | ﹤0.01% |
78,507
-81,256
| -51% | -$3.12M |
|
|
RAD
2619
PUT
DELISTED
Rite Aid Corporation
RAD
| $3.1M | ﹤0.01% |
+36,450
| New | +$4.39M |
|
|
NE
2620
PUT
DELISTED
Noble Corporation
NE
| $3.1M | ﹤0.01% |
500,000
-49,500
| -9% | -$333K |
|
|
AMT.PRA
2621
DELISTED
American Tower Corporation
AMT.PRA
| $3.09M | ﹤0.01% |
27,087
-46
| -0.2% | -$4.89K |
|
|
ACET
2622
DELISTED
Aceto Corp
ACET
| $3.09M | ﹤0.01% |
195,516
-113,542
| -37% | -$1.94M |
|
2623
Agree Realty
ADC
$9.34B
| $3.09M | ﹤0.01% |
64,339
-61,713
| -49% | -$2.92M |
|
|
FLXN
2624
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.08M | ﹤0.01% |
114,587
-11,235
| -9% | -$229K |
|
|
MYOK
2625
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.08M | ﹤0.01% |
234,167
+64,017
| +38% | +$820K |
|
Similar funds
JP Morgan Chase's Q1 2017 Portfolio in Review
As of Q1 2017, JP Morgan Chase held 5,473 positions worth $438B, up 5.1% from $416B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2017 filing shows 430 new, 1,777 increased, 2,381 reduced and 409 closed positions. Its largest new stake was Snap: 11,202,277 shares worth $252M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.21B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2017 buy was Snap: 11,202,277 shares worth $252M.
- JP Morgan Chase added most to Apple in Q1 2017, an estimated $883M increase.
- JP Morgan Chase's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.21B.
- JP Morgan Chase fully exited Linear Technology Corp in Q1 2017, selling an estimated $282M.
- JP Morgan Chase's ten largest holdings make up 17% of its $438B portfolio in Q1 2017.
- JP Morgan Chase opened 430 new positions and closed 409 in Q1 2017.
- JP Morgan Chase's portfolio value rose 5.1% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.